Metabolic Impairment in Coronary Artery Disease: Elevated Serum Acylcarnitines Under the Spotlights

Metabolic Impairment in Coronary Artery Disease: Elevated Serum Acylcarnitines Under the Spotlights

Coronary artery disease (CAD) remains the leading cause of death worldwide. Expanding patients' metabolic phenotyping beyond clinical chemistry investigations could lead to earlier recognition of disease onset and better prevention strategies. Additionally, metabolic phenotyping, at the molecul...

Full description

Bibliographic Details
Main Authors: Joséphine Gander, Justin Carrard, Hector Gallart-Ayala, Rébecca Borreggine, Tony Teav, Denis Infanger, Flora Colledge, Lukas Streese, Jonathan Wagner, Christopher Klenk, Gilles Nève, Raphael Knaier, Henner Hanssen, Arno Schmidt-Trucksäss, Julijana Ivanisevic
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-12-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
metabolomics
coronary artery disease
carnitine
acylcarnitine
branched-chain amino acids
fatty acid oxidation (FAO)
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.792350/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2021.792350/full

Similar Items